𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estrogen receptor analysis in primary breast tumors by ligand-binding assay, immunocytochemical assay, and northern blot: a comparison

✍ Scribed by Marc Lacroix; Gilbert Querton; Philippe Hennebert; Denis Larsimont; Guy Leclercq

Book ID
110367560
Publisher
Springer US
Year
2001
Tongue
English
Weight
125 KB
Volume
67
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Estrogen and progesterone receptors in b
Estrogen and progesterone receptors in breast cancer: Comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay
✍ Antonio Cavaliere; Emilio Bucciarelli; Angelo Sidoni; Giuseppina Bianchi; Nadia πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 453 KB πŸ‘ 2 views

Evaluation of estrogen (ER) and progesterone (PR) receptor content is now an important procedure in the management of breast cancer patients. Production of monoclonal antibodies to ER and PR has permitted development of an enzyme immunoassay (EIA) and immunocytochemical assay (ICA). This study compa

Comparison of estrogen receptor determin
Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials
✍ Steven R. Alberts; James N. Ingle; Patrick R. Roche; Stephen S. Cha; Lester E. W πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 830 KB

## BACKGROUND. The measurement of estrogen receptors (ER) in breast cancer specimens has traditionally been assessed with a tlextran-coated charcoal assay (DCCA). More recently the immunohistochemical staining (IHC) method has gained increasing popularity because of its ability to use fixed tissue

Estrogen receptor (ER) and progesterone
Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study
✍ Richard M. Elledge; Stephanie Green; Reginald Pugh; D. Craig Allred; Gary M. Cla πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 133 KB πŸ‘ 2 views

Results of estrogen receptor (ER) and progesterone receptor (PgR) ligand-binding assays (LBAs) are strongly correlated with ER and PgR by immuno-histochemistry (IHC). To investigate whether ER and PgR by IHC are also strongly correlated with tamoxifen response, time to treatment failure (TTF) and ov